613 related articles for article (PubMed ID: 21374084)
21. Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model.
Labrinidis A; Hay S; Liapis V; Findlay DM; Evdokiou A
Int J Cancer; 2010 Jul; 127(2):345-54. PubMed ID: 19924813
[TBL] [Abstract][Full Text] [Related]
22. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
[TBL] [Abstract][Full Text] [Related]
23. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin.
Mauldin GN; Matus RE; Withrow SJ; Patnaik AK
J Vet Intern Med; 1988; 2(4):177-80. PubMed ID: 3230557
[TBL] [Abstract][Full Text] [Related]
24. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
[TBL] [Abstract][Full Text] [Related]
25. Video-assisted microwave ablation for the treatment of a metastatic lung lesion in a dog with appendicular osteosarcoma and hypertrophic osteopathy.
Mazzaccari K; Boston SE; Toskich BB; Bowles K; Case JB
Vet Surg; 2017 Nov; 46(8):1161-1165. PubMed ID: 28940654
[TBL] [Abstract][Full Text] [Related]
26. What do we know about canine osteosarcoma treatment? Review.
Szewczyk M; Lechowski R; Zabielska K
Vet Res Commun; 2015 Mar; 39(1):61-7. PubMed ID: 25422073
[TBL] [Abstract][Full Text] [Related]
27. Use of cisplatin for treatment of appendicular osteosarcoma in dogs.
Shapiro W; Fossum TW; Kitchell BE; Couto CG; Theilen GH
J Am Vet Med Assoc; 1988 Feb; 192(4):507-11. PubMed ID: 3163684
[TBL] [Abstract][Full Text] [Related]
28. Anticancer effects of zoledronic acid against human osteosarcoma cells.
Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
[TBL] [Abstract][Full Text] [Related]
29. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs.
Kent MS; Strom A; London CA; Seguin B
J Vet Intern Med; 2004; 18(4):540-4. PubMed ID: 15320595
[TBL] [Abstract][Full Text] [Related]
30. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.
Fan TM; de Lorimier LP; O'Dell-Anderson K; Lacoste HI; Charney SC
J Vet Intern Med; 2007; 21(3):431-9. PubMed ID: 17552447
[TBL] [Abstract][Full Text] [Related]
31. Canine osteosarcoma: amputation and chemoimmunotherapy.
MacEwen EG; Kurzman ID
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571
[TBL] [Abstract][Full Text] [Related]
32. Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma.
Kim EH; Kim MS; Lee KH; Koh JS; Jung WG; Kong CB
Oncotarget; 2016 Oct; 7(43):70869-70880. PubMed ID: 27765919
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.
Heishima K; Meuten T; Yoshida K; Mori T; Thamm DH
BMC Vet Res; 2019 Jan; 15(1):39. PubMed ID: 30683101
[TBL] [Abstract][Full Text] [Related]
34. Pasteurized tumoral autograft and adjuvant chemotherapy for the treatment of canine distal radial osteosarcoma: 13 cases.
Morello E; Vasconi E; Martano M; Peirone B; Buracco P
Vet Surg; 2003; 32(6):539-44. PubMed ID: 14648532
[TBL] [Abstract][Full Text] [Related]
35. Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs.
Wright T; Brisson BA; Wood GA; Oblak M; Mutsaers AJ; Sabine V; Skowronski K; Belanger C; Tiessen A; Bienzle D
Cytometry A; 2019 Sep; 95(9):997-1007. PubMed ID: 31282052
[TBL] [Abstract][Full Text] [Related]
36. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
37. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.
Hiraga T; Williams PJ; Ueda A; Tamura D; Yoneda T
Clin Cancer Res; 2004 Jul; 10(13):4559-67. PubMed ID: 15240548
[TBL] [Abstract][Full Text] [Related]
38. Ipsilateral vascularised ulnar transposition autograft for limb-sparing surgery of the distal radius in 2 dogs with osteosarcoma.
Irvine-Smith GS; Lobetti RG
J S Afr Vet Assoc; 2006 Sep; 77(3):150-4. PubMed ID: 17137057
[TBL] [Abstract][Full Text] [Related]
39. Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.
Hung TT; Chan J; Russell PJ; Power CA
PLoS One; 2011; 6(5):e19389. PubMed ID: 21603655
[TBL] [Abstract][Full Text] [Related]
40. Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo.
Holen I; Walker M; Nutter F; Fowles A; Evans CA; Eaton CL; Ottewell PD
Clin Exp Metastasis; 2016 Mar; 33(3):211-24. PubMed ID: 26585891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]